Pirfenidone

Intervention

9 papers12 findings

PubChemChEBIMeSH

  • 3 independent labs in 3 countries
  • 5 trials, 3 about aging
  • Funders: European Regional Development Fund and 8 more
  • 2 of 5 trials sponsored by its developers
  • Humans1
  • Animals3
  • Cells2

Outcomes

10

COL1A1

downin mouse cells2

2 studies
  1. Pirfenidone decreases COL1A1 in mouse cells.

    “Pirfenidone significantly reduced Col1a1 expression.”

    Cellstreated with a pro-fibrotic or a pro-inflammatory stimulusovary

    Systemic low-dose anti-fibrotic treatment attenuates ovarian aging in the mouse

    GeroScienceSep 16, 2024

  2. Pirfenidone decreases COL1A1 in mouse cells.

    “Pirfenidone significantly reduced Col1a1 expression.”

    Cellsin ovarian stromal cells

    Systemic low-dose anti-fibrotic treatment attenuates ovarian aging in the mouse

    bioRxiv : the preprint server for biologyJun 25, 2024Preprint

More on COL1A1

Ovarian function

upin mice2

2 studies
  1. Pirfenidone improves ovarian function in mice.

    “Ovarian function was improved in Pirfenidone-treated mice as evidenced by increased follicle and corpora lutea number, AMH levels, and improved estrous cyclicity.”

    Animalsmini-osmotic pumpsovary6 weeksfemales

    Systemic low-dose anti-fibrotic treatment attenuates ovarian aging in the mouse

    GeroScienceSep 16, 2024

  2. Pirfenidone improves ovarian function in mice.

    “Ovarian function was improved in Pirfenidone-treated mice as evidenced by increased follicle and corpora lutea number, AMH levels, and improved estrous cyclicity.”

    Animalsmini-osmotic pumpsovary6-weeks

    Systemic low-dose anti-fibrotic treatment attenuates ovarian aging in the mouse

    bioRxiv : the preprint server for biologyJun 25, 2024Preprint

profibrotic programs

downin humans1

1 study
  1. Pirfenidone inhibits profibrotic programs in humans.

    “CD8+/CD4 + T cells, lymphoid endothelial cells and dendritic cells”

    Reviewin fILD

    Bridging the Gap: The Emerging Role of memory CD8+ T Cells in Fibrotic Interstitial Lung Disease

    American journal of respiratory cell and molecular biologyJun 19, 2026

Ovarian fibrosis

downin mice1

1 study
  1. Pirfenidone decreases ovarian fibrosis in mice.

    “Pirfenidone mitigated the age-dependent increase in ovarian fibrosis without impacting overall health parameters.”

    Animalsmini-osmotic pumpsovary6 weeksfemales

    Systemic low-dose anti-fibrotic treatment attenuates ovarian aging in the mouse

    GeroScienceSep 16, 2024

Extracellular matrix remodelling

downin mice1

1 study
  1. Pirfenidone decreases extracellular matrix remodelling in mice.

    “Pirfenidone mitigated the age-dependent increase in ovarian fibrosis without impacting overall health parameters.”

    Animalsmini-osmotic pumpsovary6-weeks

    Systemic low-dose anti-fibrotic treatment attenuates ovarian aging in the mouse

    bioRxiv : the preprint server for biologyJun 25, 2024Preprint

More on Extracellular matrix remodelling

MAPK/ERK signalling

downin human cells1

1 study
  1. Pirfenidone inhibits MAPK/ERK signalling in human cells.

    “PFD and NTD only inhibited ERK1/2 phosphorylation”

    Cellsinduced by IL-11

    Pirfenidone and nintedanib attenuates pulmonary artery endothelial and smooth muscle cells transformations induced by IL-11

    European journal of pharmacologyMar 30, 2024

More on MAPK/ERK signalling

Cellular senescence

downin human cells1

1 study
  1. Pirfenidone inhibits cellular senescence in human cells.

    “inhibitory effect of PFD and NTD on IL-11-induced endothelial and muscle cells proliferation and senescence”

    CellsIL-11-induced

    Pirfenidone and nintedanib attenuates pulmonary artery endothelial and smooth muscle cells transformations induced by IL-11

    European journal of pharmacologyMar 30, 2024

More on Cellular senescence

endothelial-to-mesenchymal transition

downin human cells1

1 study
  1. Pirfenidone decreases endothelial-to-mesenchymal transition in human cells.

    “nintedanib (NTD) and pirfenidone (PFD) ameliorates endothelial to mesenchymal transition (EnMT)”

    Cellsinduced by IL-11

    Pirfenidone and nintedanib attenuates pulmonary artery endothelial and smooth muscle cells transformations induced by IL-11

    European journal of pharmacologyMar 30, 2024

Ovulation

upin mice1

1 study
  1. Pirfenidone improves ovulation in mice.

    “antifibrosis drugs (pirfenidone and BGP-15) eliminate fibrotic collagen and restore ovulation in reproductively old and obese mice”

    Animalsin reproductively old and obese miceovaryfemales

    Female reproductive life span is extended by targeted removal of fibrotic collagen from the mouse ovary

    Science advancesJun 17, 2022

Fibrotic collagen

downin mice1

1 study
  1. Pirfenidone decreases fibrotic collagen in mice.

    “antifibrosis drugs (pirfenidone and BGP-15) eliminate fibrotic collagen and restore ovulation in reproductively old and obese mice”

    Animalsin reproductively old and obese miceovaryfemales

    Female reproductive life span is extended by targeted removal of fibrotic collagen from the mouse ovary

    Science advancesJun 17, 2022

More on Fibrotic collagen

Trials

3 about aging, of 5

Development

Companies
  • Avalyn PharmaPhase 2pulmonary fibrosis, progressive pulmonary fibrosis

Trial sponsors

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 1May 2026: 0Jun 2026: 1Jul 2026: 1Aug 2026: 0Sep 2026: 0Oct 2026: 03 in 12 months